Lexicon Pharmaceuticals
LXRX
#7252
Rank
HK$3.70 B
Marketcap
HK$10.19
Share price
-5.76%
Change (1 day)
77.18%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -HK$1.48

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$1.48. In 2024 the company made an earnings per share (EPS) of -HK$4.98 an increase over its 2023 EPS that were of -HK$6.22.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$1.48-70.36%
2024-HK$4.98-20%
2023-HK$6.2231.15%
2022-HK$4.75-0%
2021-HK$4.7510.91%
2020-HK$4.28-145.08%
2019HK$9.49-206.09%
2018-HK$8.95-5.74%
2017-HK$9.49-10.95%
2016-HK$10.662640%
2015-HK$0.39-96.34%
2014-HK$10.62-2.53%
2013-HK$10.89-9.09%
2012-HK$11.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
-HK$596.89 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$338.01-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-HK$46.22 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$21.16-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$134.92-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-HK$4.20 184.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$34.78-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$18.60-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-HK$5.84 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA